[Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions].
作者信息
Motolese M
出版信息
G Ital Cardiol. 1978;8(3):333-49.
PMID:25219
Abstract
摘要
相似文献
1
2
[Beta-adrenergic inhibitors and coronary insufficiency].
Therapie. 1985 Nov-Dec;40(6):393-6.
3
[The beta-blockers in coronary disease].
Rev Prat. 1984 Apr 1;34(19):953-64.
4
5
[Therapy using beta-receptor blockaders in coronary disease].
Internist (Berl). 1978 Sep;19(9):520-6.
6
[Up-dating the treatment with beta-blockaders in cardiology].
Rev Clin Esp. 1977 Oct 15;147(1):103-12.
7
[Beta-adrenergic receptor blockers in clinical practice].
Orv Hetil. 2004 Sep 19;145(38):1951-60.
8
[Beta-adrenergic blockaders in cardiology].
Arq Bras Cardiol. 1979 Oct;33(4):283-92.
9
[Choice of beta-blocking agents].
Duodecim. 1986;102(22):1642-50.
10
Beta blockade.
Indian Heart J. 1972 Jun;24:Suppl 1:143-5.
引用本文的文献
1
Hemodynamic effects of somatostatin in insulin-dependent diabetic subjects.
Acta Diabetol Lat. 1979 Oct-Dec;16(4):331-7. doi: 10.1007/BF02587654.
Zotero 插件